Related Experiment Video
Updated: Jul 11, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival.
B Chaigne-Delalande1, G Anies, I Kramer
1European Institute of Chemistry and Biology, University of Bordeaux I, Pessac, France.
Oncogene
|October 2, 2007
Summary
Rac signaling activates Akt in suspended T cells, a pathway dependent on SHIP and distinct from adherent cells. This suggests a unique survival mechanism for non-adherent cells.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Immunology
Background:
- Rac GTPases are critical regulators of cellular processes.
- Akt signaling pathways are crucial for cell survival and proliferation.
- Cell adhesion status can influence intracellular signaling.
Purpose of the Study:
- To investigate the role of Rac in Akt activation in T lymphocytes.
- To determine the influence of cell adherence on Rac-mediated Akt signaling.
- To elucidate the involvement of SHIP and PTEN in this pathway.
Main Methods:
- Culturing T lymphocytes in suspension versus adherence.
- Utilizing constitutively active V12Rac mutants.
- Assessing Akt activity and Rac-Akt molecular complex formation.
- Employing genetic knockouts for SHIP and PTEN.
Main Results:
- V12Rac-mediated Akt stimulation and Rac-Akt complex formation occurred exclusively in suspended cells.
- This pathway is dependent on SHIP, but its mechanism differs from SHIP's phosphoinositide dephosphorylation role.
- Adherent cells lacking SHIP, but not PTEN, could activate Akt via the Rac pathway.
Conclusions:
- A novel Rac to Akt signaling pathway exists, regulated by SHIP and active only in suspended cells.
- This pathway represents a distinct survival mechanism activated upon loss of cell-substrate or cell-cell contact.
- Findings highlight the context-dependent nature of Rac-Akt signaling and its implications for cell survival.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:21Cell Polarization by Rho Proteins
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...